Evidence map›Paper›PMID 27833380›Full record

ReviewWorld journal of gastroenterology2016

Indications and surgical options for small bowel, large bowel and perianal Crohn's disease.

James Wt Toh, Peter Stewart, Matthew Jfx Rickard, Rupert Leong, Nelson Wang, Christopher J Young

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Stricture dilationTherapeutic advances in gastroenterology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

James Wt TohJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Peter StewartJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Matthew Jfx RickardJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Rupert LeongJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Nelson WangJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Christopher J YoungJames WT Toh, Peter Stewart, Matthew JFX Rickard, Christopher J Young, Department of Colorectal Surgery, Concord Repatriation General Hospital, NSW 2139, Australia.
Royal Prince Alfred Hospital · AUConcord Repatriation General Hospital · AUIngham Institute · AULiverpool Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advancements in medical therapy of Crohn's disease (CD), majority of patients with CD will eventually require surgical intervention, with at least a third of patients requiring multiple surgeries. It is important to understand the role and timing of surgery, with the goals of therapy to reduce the need for surgery without increasing the odds of emergency surgery and its associated morbidity, as well as to limit surgical recurrence and avoid intestinal failure. The profile of CD patients requiring surgical intervention has changed over the decades with improvements in medical therapy with immunomodulators and biological agents. The most common indication for surgery is obstruction from stricturing disease, followed by abscesses and fistulae. The risk of gastrointestinal bleeding in CD is high but the likelihood of needing surgery for bleeding is low. Most major gastrointestinal bleeding episodes resolve spontaneously, albeit the risk of re-bleeding is high. The risk of colorectal cancer associated with CD is low. While current surgical guidelines recommend a total proctocolectomy for colorectal cancer associated with CD, subtotal colectomy or segmental colectomy with endoscopic surveillance may be a reasonable option. Approximately 20%-40% of CD patients will need perianal surgery during their lifetime. This review assesses the practice parameters and guidelines in the surgical management of CD, with a focus on the indications for surgery in CD (and when not to operate), and a critical evaluation of the timing and surgical options available to improve outcomes and reduce recurrence rates.

Indexed as

Crohn DiseaseDigestive System Surgical ProceduresHumansIntestine, LargeIntestine, SmallColon cancerCrohn’s diseaseInflammatory bowel diseaseMajor abdominal surgeryPerianalSurgery

Identifiers

PMID27833380
PMCPMC5083794
OpenAlexW2542724017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.